Estrogen inhibits vaginal tropoelastin and TGF-β1 production

[1]  H. Bogner,et al.  Self-reported estrogen use and newly incident urinary incontinence among postmenopausal community-dwelling women , 2012, Menopause.

[2]  K. Candiotti,et al.  TGF-beta 1 is a potential regulator of vaginal tropoelastin production , 2012, International Urogynecology Journal.

[3]  Bertha Chen,et al.  Alterations in connective tissue metabolism in stress incontinence and prolapse. , 2011, The Journal of urology.

[4]  G. Lin,et al.  Effects of birth trauma and estrogen on urethral elastic fibers and elastin expression. , 2010, Urology.

[5]  Takeshi Imamura,et al.  Estrogen Inhibits Transforming Growth Factor β Signaling by Promoting Smad2/3 Degradation* , 2010, The Journal of Biological Chemistry.

[6]  Ling Ouyang,et al.  [Expression and significance of elastin and fibulin-5 in anterior vaginal tissue of women with pelvic organ prolapse]. , 2009, Zhonghua fu chan ke za zhi.

[7]  J. Foster,et al.  Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[8]  C. Thomssen,et al.  Changes in the extracellular matrix in periurethral tissue of women with stress urinary incontinence. , 2006, Acta histochemica.

[9]  Y. Wen,et al.  Do extracellular matrix protein expressions change with cyclic reproductive hormones in pelvic connective tissue from women with stress urinary incontinence? , 2006, Human reproduction.

[10]  E. Vittinghoff,et al.  Postmenopausal Hormone Therapy: Does It Cause Incontinence? , 2005, Obstetrics and gynecology.

[11]  Y. Wen,et al.  Elastin metabolism in pelvic tissues: is it modulated by reproductive hormones? , 2005, American journal of obstetrics and gynecology.

[12]  R. Wallace,et al.  Effects of estrogen with and without progestin on urinary incontinence. , 2005, The Journal of urology.

[13]  S. Goldstein,et al.  Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. , 2002, American journal of obstetrics and gynecology.

[14]  N. Watson,et al.  Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator. , 2002, British journal of clinical pharmacology.

[15]  C. Christiansen,et al.  Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. , 2001, JAMA.

[16]  L. Horwitz,et al.  Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta1. , 1998, The Journal of surgical research.

[17]  K. Flanders,et al.  Transforming growth factors beta 1, beta 2, and beta 3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: a comparison to other estrogen-regulated genes. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[18]  J. Uitto,et al.  Transforming growth factor-beta up-regulates human elastin promoter activity in transgenic mice. , 1994, Biochemical and biophysical research communications.

[19]  J. Uitto,et al.  Transforming growth factor-beta up-regulates elastin gene expression in human skin fibroblasts. Evidence for post-transcriptional modulation. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[20]  K. Candiotti,et al.  Levormeloxifene inhibits vaginal tropoelastin and transforming growth factor beta 1 production. , 2011, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[21]  K. Candiotti,et al.  The effects of estrogen, progesterone and polypropylene mesh on vaginal smooth muscle cell proliferation. , 2010, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[22]  C. Glazener,et al.  Oestrogen therapy for urinary incontinence in post-menopausal women. , 2009, The Cochrane database of systematic reviews.

[23]  K. Choy,et al.  17beta-estradiol suppresses proliferation of fibroblasts derived from cardinal ligaments in patients with or without pelvic organ prolapse. , 2006, Human reproduction.

[24]  K. Choy,et al.  17β-Estradiol suppresses proliferation of fibroblasts derived from cardinal ligaments in patients with or without pelvic organ prolapse , 2006 .